Buy MDMB-INACA Cas 2709672-58-0
Buy MDMB-INACA Cas 2709672-58-0
Description: MDMB-INACA is a synthetic cannabinoid precursor that can be used to produce MDMB-4en-PINACA, MDMB-BINACA, MDMB-PINACA, 4F-MDMB-BINACA, and other structurally related synthetic cannabinoids. To date, MDMB-INACA has appeared alongside MDMB-4en-PINACA and MDMB-BINACA in drug materials and/or toxicology samples tested by our laboratory in the United States. Synthetic cannabinoid precursors (e.g., ADB-INACA, MDMB-5’Br-INACA) began to appear after the implementation of a national class-wide synthetic cannabinoid scheduling action imposed by China in July 2021.
Sample Source: Drug material – United States (e.g., New York).
Sample Appearance: Drug material – impregnated paper.
Pharmacology: The activity and potency of MDMB-INACA are unknown; however, based on structurally similar synthetic cannabinoid precursors, MDMB-INACA is expected to be inactive or have low potency.
Toxicology: MDMB-INACA has been detected in seven toxicology cases at the CFSRE.
Drug Materials: MDMB-INACA has been detected in one drug material at the CFSRE.
Demographics / Geographics: Cases originated from three states, including Texas, New York, and Maryland. In death investigations, decedents were predominantly male, ranging in age from 20s-40s.
Legal Status: MDMB-INACA is not explicitly scheduled in the United States.
- Class:
- Cannabinoid
- Appearance:
- Paper
- Formula:
- C15H19N3O3
- MW:
- 289.33
- [M+]:
- 289
- [M+H]+:
- 290.1499
- IUPAC:
- methyl 2-(1H-indazole-3-carbonylamino)-3,3-dimethyl-butanoate
Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
- CAS No.
- 2709672-58-0
- Chemical Name:
- Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
- Synonyms
- MDMB-INACA;Tryptophan Impurity 96;N-(1H-Indazol-3-ylcarbonyl)-3methyl-L-valine methyl ester;L-Valine, N-(1H-indazol-3-ylcarbonyl)-3-methyl-, methyl ester;Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate;methyl (2S)-2-(1H-indazole-3-carbonylamino)-3,3-dimethylbutanoate
- CBNumber:
- CB210987337
- Molecular Formula:
- C15H19N3O3
- Molecular Weight:
- 289.34
- MDL Number:
- MOL File:
- 2709672-58-0.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| MDMB-INACA ≥98% | 27248 | 1mg | $91 |
| MDMB-INACA ≥98% | 27248 | 5mg | $316 |
| Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate ≥98% | 27248 | 1 mg | $81 |
| Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate ≥98% | 27248 | 5 mg | $278 |
| MDMB-INACA ≥98% | AA01XHO8 | 1mg | $91 |
| Boiling point | 523.1±30.0 °C(Predicted) |
|---|---|
| Density | 1.213±0.06 g/cm3(Predicted) |
| solubility | DMF: 12.5 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 10 mg/ml; Ethanol: 3 mg/ml |
| form | A crystalline solid |
| pka | 11.72±0.46(Predicted) |
| InChI | InChI=1/C15H19N3O3/c1-15(2,3)12(14(20)21-4)16-13(19)11-9-7-5-6-8-10(9)17-18-11/h5-8,12H,1-4H3,(H,16,19)(H,17,18)/t12-/s3 |
| InChIKey | QEXPVGIGOZJEOO-PLAQIDKDNA-N |
| SMILES | C(C1=NNC2=CC=CC=C12)(=O)N[C@@H](C(C)(C)C)C(=O)OC |&1:12,r| |
| FDA UNII | N2R368RE68 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302+H312+H332 | |||||||||
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P321-P330-P362+P364-P501 | |||||||||
| NFPA 704 |
|
Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 27248 | MDMB-INACA ≥98% | 2709672-58-0 | 1mg | $91 | 2026-04-30 | Buy |
| Cayman Chemical | 27248 | MDMB-INACA ≥98% | 2709672-58-0 | 5mg | $316 | 2026-04-30 | Buy |
| Cayman Chemical | 27248 | Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate ≥98% | 2709672-58-0 | 1 mg | $81 | 2024-03-01 | Buy |
| Cayman Chemical | 27248 | Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate ≥98% | 2709672-58-0 | 5 mg | $278 | 2024-03-01 | Buy |
| aablocks | AA01XHO8 | MDMB-INACA ≥98% | 2709672-58-0 | 1mg | $91 | 2026-06-01 | Buy |
Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate Chemical Properties, Uses, Production
Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate Preparation Products And Raw materials
Raw materials
Preparation Products
Methyl (S)-2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate Suppliers
MDMB-5Br-INACA is an indazole-3-carboxamide derivative which has been sold as a designer drug.[2] Surprisingly it has been reported to produce psychoactive activity despite the lack of a “tail” group at the indazole 1-position, but is likely of relatively low potency as a CB1 agonist and has been encountered being misrepresented as other illicit drugs such as MDMA.[3][4]
This reported psychoactive activity has been limitedly reported on but could be related to activity beyond the cannabinoid receptors due to vague structural relation to compounds like 1Z2MAP1O and α-Methylisotryptamine. [citation needed]
Use as a precursor
MDMB-5Br-INACA is believed to be used as a precursor in the synthesis of synthetic cannabinoids. It has been sold online as a “chemistry kit” with other compounds required to complete the reaction. This reaction would complete MDMB-5Br-INACA by giving it a “tail” group required for high cannabinoid activity. Other precursors lacking a tail chain have also been marketed such as (ADB-5-Br-INACA),[5] (CH-IATA), (ADB-IACA), and (ADB-5’Br-EZO-CA). This may be due to increasing legality changes worldwide on synthetic cannabinoids.[6][7]
Legality
In the United States, MDMB-5Br-INACA is unscheduled at the federal level as of May 22nd, 2023.
North Dakota has placed MDMB-5Br-INACA (along with ADB-5’Br-BINACA, ADB-5’Br-BUTINACA and ADB-5-Br-INACA) into Schedule I on 04/27/2023.[8]
Reviews
There are no reviews yet.